Inozyme Pharma, Inc. (INZY)
USD 0.97
(9.37%)
USD 0.97
(9.37%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -70.67 Million | -57.76 Million | -48.15 Million | -35.97 Million | -18.81 Million | -9.43 Million |
| Net Income | -71.16 Million | -67.06 Million | -56.62 Million | -56.42 Million | -19.72 Million | -6.96 Million |
| Depreciation & Amortization | 1.29 Million | 744 Thousand | 674 Thousand | 217 Thousand | 83 Thousand | 26 Thousand |
| Deferred income taxes | 1.37 Million | - | 170 Thousand | - | - | - |
| Stock-based compensation | 7.03 Million | 7.67 Million | 7.16 Million | 2.3 Million | 301 Thousand | 444 Thousand |
| Change in working capital | -3.08 Million | 2.01 Million | 85 Thousand | -111 Thousand | 601 Thousand | 1.43 Million |
| Other non-cash items | -6.13 Million | -1.12 Million | 378 Thousand | 18.03 Million | -71 Thousand | -4.37 Million |
| Investing Cash Flow | -53.64 Million | -5.4 Million | 42.79 Million | -117.17 Million | -8.39 Million | 9 Million |
| Investments in PPE | -298 Thousand | -410 Thousand | -397 Thousand | -568 Thousand | -139 Thousand | -259 Thousand |
| Acquisitions | 53.34 Thousand | 4993.00 | -43.19 Thousand | 116.61 Thousand | 8252.00 | - |
| Investment purchases | -269.33 Million | -151.99 Million | -121.96 Million | -177.92 Million | -24.66 Million | -13.56 Million |
| Sales/Maturities of investments | 215.98 Million | 147 Million | 165.16 Million | 61.31 Million | 16.41 Million | 22.83 Million |
| Other Investing Activities | -53.34 Thousand | -4993.00 | 43.19 Thousand | -116.61 Thousand | -8252.00 | 9.26 Million |
| Financing Cash Flow | 125.96 Million | 72.78 Million | 609 Thousand | 149.81 Million | 22.97 Million | 31.94 Million |
| Debt repayment | -40 Million | -4.05 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 206 Thousand | 92 Thousand | - | - | - | - |
| Common Stock Issuance | 85.96 Million | 68.73 Million | 609 Thousand | 115.97 Million | 22.97 Million | 31.94 Million |
| Other Financing Activities | 85.96 Million | 68.73 Million | 609.00 | 33.84 Million | 22.97 Thousand | 31.94 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -1.37 Million | 150 Thousand | -675 Thousand | 2.09 Million | -83 Thousand | 802 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.7 Million | 1.86 Million | 760 Thousand | -2.2 Million | 684 Thousand | 629 Thousand |
| Cash at beginning of period | 32.91 Million | 23.67 Million | 28.39 Million | 31.73 Million | 35.96 Million | 4.45 Million |
| Cash at end of period | 34.58 Million | 33.26 Million | 23.67 Million | 28.39 Million | 31.73 Million | 35.96 Million |
| Capital Expenditure | -298 Thousand | -410 Thousand | -397 Thousand | -568 Thousand | -139 Thousand | -259 Thousand |
| Effect of forex changes on cash | -18 Thousand | -25 Thousand | 24 Thousand | - | - | - |
| Net cash flow / Change in cash | 1.67 Million | 9.59 Million | -4.72 Million | -3.34 Million | -4.23 Million | 31.51 Million |
| Free Cash Flow | -70.97 Million | -58.17 Million | -48.55 Million | -36.54 Million | -18.94 Million | -9.69 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -24.57 Million | -27.03 Million | -23.34 Million | -21.54 Million | -71.16 Million | -16.63 Million |
| Depreciation & Amortization | -4.3 Million | 188 Thousand | 182 Thousand | 306 Thousand | 1.29 Million | 208 Thousand |
| Deferred income taxes | - | - | - | -3.12 Million | 1.37 Million | -1.48 Million |
| Stock-based compensation | 2.12 Million | 2.15 Million | 1.69 Million | 1.67 Million | 7.03 Million | 1.67 Million |
| Change in working capital | -819 Thousand | 2.15 Million | -1.34 Million | 2.92 Million | -3.08 Million | -2.93 Million |
| Other non-cash items | 3.03 Million | 43 Thousand | -664 Thousand | 1.28 Million | -6.13 Million | 313 Thousand |
| Investing Cash Flow | 23.34 Million | 17.81 Million | 10.39 Million | -6.47 Million | -53.64 Million | -44.61 Million |
| Investments in PPE | -13 Thousand | - | -32 Thousand | -105 Thousand | -298 Thousand | -7000.00 |
| Acquisitions | - | - | - | 6365.00 | 53.34 Thousand | 44.6 Thousand |
| Investment purchases | -27.71 Million | -49.46 Million | -49.32 Million | -57.86 Million | -269.33 Million | -104.59 Million |
| Sales/Maturities of investments | 51.07 Million | 67.27 Million | 59.75 Million | 51.5 Million | 215.98 Million | 59.98 Million |
| Other Investing Activities | - | 17.81 Million | 10.42 Million | -6365.00 | -53.34 Thousand | -44.6 Thousand |
| Financing Cash Flow | 10.52 Million | 458 Thousand | 159 Thousand | 12.51 Million | 125.96 Million | 69.71 Million |
| Debt repayment | - | - | - | -12.5 Million | -40 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | 148 Thousand | 110 Thousand | 206 Thousand | - |
| Common Stock Issuance | 9.82 Million | 458 Thousand | 159 Thousand | 16 Thousand | 85.96 Million | 69.71 Million |
| Other Financing Activities | 700 Thousand | 458 Thousand | 11 Thousand | 12.51 Million | 85.96 Million | 69.71 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -1.31 Million | 1.36 Million | 1 Million | -843 Thousand | -1.37 Million | -5000.00 |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.54 Million | 798 Thousand | -2.34 Million | 3.76 Million | -1.7 Million | -2.93 Million |
| Cash at beginning of period | 15.23 Million | 20.61 Million | 34.58 Million | 46.89 Million | 32.91 Million | 41.15 Million |
| Cash at end of period | 24.88 Million | 15.23 Million | 20.61 Million | 34.58 Million | 34.58 Million | 47.2 Million |
| Capital Expenditure | -13 Thousand | - | -32 Thousand | -105 Thousand | -298 Thousand | -7000.00 |
| Effect of forex changes on cash | -1000.00 | -1000.00 | 10 Thousand | 134 Thousand | -18 Thousand | -182 Thousand |
| Net cash flow / Change in cash | 9.65 Million | -5.38 Million | -13.97 Million | -12.3 Million | 1.67 Million | 6.05 Million |
| Free Cash Flow | -24.54 Million | -23.65 Million | -24.56 Million | -18.59 Million | -70.97 Million | -18.87 Million |
QYOUF
RNT
300308
WLFD
301163
1245